Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$779.98M
Total Bought
$73.88M
Total Sold
$176.80M
Net Transaction
-$102.92M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
SPDR S&P 500 ETF TR(SPY)917,141974,641+57,500435,926509,80565.36%+73,879
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440118,371125,11316.04%+6,742
ORIC PHARMACEUTICALS INC(ORIC)989,410989,41009,10313,6041.74%+4,502
TENAYA THERAPEUTICS INC1,015,7051,015,70503,2915,3120.68%+2,021
NGM BIOPHARMACEUTICALS INC992,168992,16808521,5780.20%+725
SURROZEN INC87,69687,69608241,3780.18%+553
FOGHORN THERAPEUTICS INC1,573,7611,573,761010,15110,5601.35%+409
SURROZEN INC170,833170,8330350.00%+2
ALECTOR INC1,307,8581,307,858010,4377,8731.01%-2,563
PMV PHARMACEUTICALS INC2,627,6432,627,64308,1464,4670.57%-3,679
23ANDME HOLDING CO10,243,12210,243,12209,3575,4490.70%-3,908
RAPT THERAPEUTICS INC657,899657,899016,3495,9080.76%-10,441
SPDR GOLD TR(GLD)1,390,000432,271-957,729265,72688,92711.40%-176,800
Page 1 of 1